{"id":"W4378347895","doi":"10.1080/13543784.2023.2212155","title":"Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, single-dose phase I study","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Celltrion","keywords":"Tocilizumab; Medicine; Bioequivalence; Clinical endpoint; Cmax; Pharmacokinetics; Adverse effect; Internal medicine; Confidence interval; Pharmacology; Randomized controlled trial; European union; Area under the curve; Rheumatoid arthritis; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002422229,0.001129895,0.002549957,0.0003812883,0.0003838082,0.0007056507,0.0007673267,0.001302244,0.00335947],"category_scores_gemma":[0.002986142,0.0006138974,0.001253084,0.0004715284,0.001364999,0.0009160702,0.0002474258,0.002219181,0.0006334254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009496422,"about_ca_system_score_gemma":0.00161344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004691637,"about_ca_topic_score_gemma":0.0004628724,"domain_scores_codex":[0.9987819,0.0006589341,0.000092325,0.000193493,0.0001529592,0.0001204395],"domain_scores_gemma":[0.9981655,0.000458809,0.0005909218,0.0001973448,0.0001485414,0.0004388754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9278772,0.02598356,0.001220444,0.0003772214,0.0005491325,0.00005102085,0.000101431,0.0006714173,0.02370369,0.00009626942,0.0004634096,0.01890513],"study_design_scores_gemma":[0.4913146,0.4948614,0.003956743,0.0000232923,0.0009049274,0.0001148736,0.00002933232,0.001406025,0.006527225,0.0001159893,0.0007154954,0.00003005565],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946464,0.0008010616,0.001010183,0.0000915255,0.00008503409,0.002545227,0.0003185288,0.00005096368,0.0004510791],"genre_scores_gemma":[0.9940675,0.0005941961,0.001446844,0.0002642819,0.0002259195,0.002541536,0.0003230308,0.00001961602,0.000517167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00335947,"threshold_uncertainty_score":0.01281011,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1185461092162821,"score_gpt":0.3922976279886577,"score_spread":0.2737515187723757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}